vs

Side-by-side financial comparison of BlackSky Technology Inc. (BKSY) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

PETMED EXPRESS INC is the larger business by last-quarter revenue ($40.7M vs $35.2M, roughly 1.2× BlackSky Technology Inc.). BlackSky Technology Inc. runs the higher net margin — -2.5% vs -26.0%, a 23.5% gap on every dollar of revenue. On growth, BlackSky Technology Inc. posted the faster year-over-year revenue change (15.9% vs -23.3%). Over the past eight quarters, BlackSky Technology Inc.'s revenue compounded faster (20.5% CAGR vs -20.9%).

BlackSky Technology Inc. is a leading geospatial intelligence provider operating a constellation of high-revisit small Earth observation satellites. It delivers real-time satellite imagery, advanced data analytics, and dynamic monitoring solutions to government, defense, critical infrastructure, and commercial clients globally to support data-driven operational decision-making.

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

BKSY vs PETS — Head-to-Head

Bigger by revenue
PETS
PETS
1.2× larger
PETS
$40.7M
$35.2M
BKSY
Growing faster (revenue YoY)
BKSY
BKSY
+39.2% gap
BKSY
15.9%
-23.3%
PETS
Higher net margin
BKSY
BKSY
23.5% more per $
BKSY
-2.5%
-26.0%
PETS
Faster 2-yr revenue CAGR
BKSY
BKSY
Annualised
BKSY
20.5%
-20.9%
PETS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
BKSY
BKSY
PETS
PETS
Revenue
$35.2M
$40.7M
Net Profit
$-868.0K
$-10.6M
Gross Margin
23.3%
Operating Margin
-11.8%
-25.7%
Net Margin
-2.5%
-26.0%
Revenue YoY
15.9%
-23.3%
Net Profit YoY
95.5%
-1392.6%
EPS (diluted)
$0.04
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BKSY
BKSY
PETS
PETS
Q4 25
$35.2M
$40.7M
Q3 25
$19.6M
$44.4M
Q2 25
$22.2M
$51.2M
Q1 25
$29.5M
$50.8M
Q4 24
$30.4M
$52.0M
Q3 24
$22.5M
$58.0M
Q2 24
$24.9M
$66.2M
Q1 24
$24.2M
$65.1M
Net Profit
BKSY
BKSY
PETS
PETS
Q4 25
$-868.0K
$-10.6M
Q3 25
$-15.3M
$-8.5M
Q2 25
$-41.2M
$-34.2M
Q1 25
$-12.8M
$-11.6M
Q4 24
$-19.4M
$-707.0K
Q3 24
$-12.6M
$2.3M
Q2 24
$-9.4M
$3.8M
Q1 24
$-15.8M
$-5.0M
Gross Margin
BKSY
BKSY
PETS
PETS
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
BKSY
BKSY
PETS
PETS
Q4 25
-11.8%
-25.7%
Q3 25
-85.8%
-18.9%
Q2 25
-62.8%
-66.7%
Q1 25
-40.5%
-11.9%
Q4 24
-20.0%
-0.9%
Q3 24
-58.7%
1.0%
Q2 24
-47.0%
6.6%
Q1 24
-54.7%
-5.9%
Net Margin
BKSY
BKSY
PETS
PETS
Q4 25
-2.5%
-26.0%
Q3 25
-78.2%
-19.2%
Q2 25
-185.8%
-66.7%
Q1 25
-43.4%
-22.9%
Q4 24
-63.9%
-1.4%
Q3 24
-55.8%
4.0%
Q2 24
-37.7%
5.7%
Q1 24
-65.2%
-7.7%
EPS (diluted)
BKSY
BKSY
PETS
PETS
Q4 25
$0.04
$-0.50
Q3 25
$-0.44
$-0.41
Q2 25
$-1.27
$-1.65
Q1 25
$-0.42
$-0.56
Q4 24
$-0.61
$-0.03
Q3 24
$-0.66
$0.11
Q2 24
$-0.52
$0.18
Q1 24
$-0.88
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BKSY
BKSY
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$124.5M
$26.9M
Total DebtLower is stronger
$201.1M
Stockholders' EquityBook value
$94.9M
$32.8M
Total Assets
$386.2M
$88.0M
Debt / EquityLower = less leverage
2.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BKSY
BKSY
PETS
PETS
Q4 25
$124.5M
$26.9M
Q3 25
$146.5M
$36.1M
Q2 25
$93.8M
$41.1M
Q1 25
$75.8M
$54.7M
Q4 24
$52.5M
$50.1M
Q3 24
$63.2M
$52.0M
Q2 24
$41.2M
$46.0M
Q1 24
$35.4M
$55.3M
Total Debt
BKSY
BKSY
PETS
PETS
Q4 25
$201.1M
Q3 25
$195.1M
Q2 25
$122.5M
Q1 25
$115.3M
Q4 24
$107.7M
Q3 24
$98.8M
Q2 24
$108.6M
Q1 24
$85.0M
Stockholders' Equity
BKSY
BKSY
PETS
PETS
Q4 25
$94.9M
$32.8M
Q3 25
$91.1M
$43.1M
Q2 25
$86.6M
$51.5M
Q1 25
$88.8M
$85.1M
Q4 24
$94.0M
$96.2M
Q3 24
$110.3M
$96.4M
Q2 24
$76.5M
$93.5M
Q1 24
$81.7M
$96.7M
Total Assets
BKSY
BKSY
PETS
PETS
Q4 25
$386.2M
$88.0M
Q3 25
$380.9M
$100.3M
Q2 25
$310.8M
$109.8M
Q1 25
$284.9M
$148.7M
Q4 24
$254.1M
$144.8M
Q3 24
$245.5M
$146.0M
Q2 24
$224.3M
$152.7M
Q1 24
$210.1M
$169.9M
Debt / Equity
BKSY
BKSY
PETS
PETS
Q4 25
2.12×
Q3 25
2.14×
Q2 25
1.41×
Q1 25
1.30×
Q4 24
1.15×
Q3 24
0.90×
Q2 24
1.42×
Q1 24
1.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BKSY
BKSY
PETS
PETS
Operating Cash FlowLast quarter
$-9.3M
$-9.2M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BKSY
BKSY
PETS
PETS
Q4 25
$-9.3M
$-9.2M
Q3 25
$-39.0M
$-2.2M
Q2 25
$-7.3M
$-12.3M
Q1 25
$27.2M
$7.0M
Q4 24
$-1.8M
$-1.2M
Q3 24
$1.0M
$7.4M
Q2 24
$-1.8M
$-8.5M
Q1 24
$-3.8M
$7.1M
Free Cash Flow
BKSY
BKSY
PETS
PETS
Q4 25
$-9.2M
Q3 25
$-4.8M
Q2 25
$-13.6M
Q1 25
$4.6M
Q4 24
$-1.9M
Q3 24
$6.1M
Q2 24
$-9.2M
Q1 24
$5.9M
FCF Margin
BKSY
BKSY
PETS
PETS
Q4 25
-22.7%
Q3 25
-10.8%
Q2 25
-26.5%
Q1 25
9.1%
Q4 24
-3.7%
Q3 24
10.6%
Q2 24
-13.9%
Q1 24
9.0%
Capex Intensity
BKSY
BKSY
PETS
PETS
Q4 25
0.1%
Q3 25
5.9%
Q2 25
2.5%
Q1 25
4.7%
Q4 24
1.5%
Q3 24
2.2%
Q2 24
1.0%
Q1 24
1.9%
Cash Conversion
BKSY
BKSY
PETS
PETS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
3.18×
Q2 24
-2.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BKSY
BKSY

Segment breakdown not available.

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons